Article info
PDFReview
Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin
- Correspondence to Dr Lilie L. Lin, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; LLLin{at}mdanderson.org
Citation
Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin
Publication history
- Received January 21, 2020
- Revision received February 21, 2020
- Accepted February 24, 2020
- First published March 18, 2020.
Article Versions
- You are currently viewing a Previous version of this article (8 February 2021).
- latest version (8 February 2021).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.